ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1471

A Comparative Study of Lupus Nephritis Class II and IgA Nephropathy: Renal Disease Other Than Lupus Nephritis in Systemic Lupus Erythematosus Patients

Eun song Kang1 and Seokchan Hong2, 1Korea University Ansan Hospital, Seoul, South Korea, 2Department of Rheumatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Meeting: ACR Convergence 2023

Keywords: Lupus nephritis, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1442–1487) SLE – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Lupus nephritis (LN) is one of major organ involvement of SLE and renal biopsy is commonly performed in SLE patients suspected of having LN to assess the severity of renal damage and guide treatment decisions. However, there have been cases where renal biopsies performed in SLE patients resulted in the diagnosis of other renal diseases, such as IgA nephropathy. The prevalence and similarities between IgA nephropathy and LN in SLE patients have not been extensively studied. This study aims to investigate the characteristics of SLE patients diagnosed with renal disease other than LN, with a focus on IgA nephropathy and its similarities and differences with class II LN.

Methods: A retrospective analysis was conducted on SLE patients who underwent renal biopsies between April 1997 and October 2022 at a single tertiary care academic center. Patients diagnosed with renal diseases other than LN were identified, with a particular focus on IgA nephropathy. Baseline characteristics, laboratory findings, and renal biopsy pathologic findings were collected and statistical analyses were performed.

Results: Among 483 SLE patients who underwent renal biopsies, 25 (5%) were diagnosed with renal diseases other than LN. The most common non-LN pathology was IgA nephropathy, accounting for 28% of cases. A comparison between patients with IgA nephropathy and class II LN showed no significant differences in age, sex, SLEDAI, eGFR or UPCR. In pathologic finding, IgA nephropathy exhibited predominant IgA staining with higher intensity, while class II LN demonstrated “Full house” pattern. Long-term renal outcomes did not significantly differ between the two groups.

Conclusion: SLE patients can have renal diseases other than LN and IgA nephropathy was the most observed non-LN pathology in SLE patients. Comparison between IgA nephropathy and class II LN revealed similarities in clinical and pathological characteristics, although there were differences in immunofluorescence findings. The long-term renal outcomes between the two groups have no significant differences. These results contribute to a better understanding of the diagnostic accuracy of renal diseases other than LN in SLE patients.

Supporting image 1

Figure 1. Comparison of Renal outcome of patients with IgA nephropathy and class II Lupus nephritis in SLE patients

Supporting image 2

Table 1. Kidney biopsy proflie of non-LN in patients with SLE

Supporting image 3

Table 2. Comparison of Kidney biopsies between IgA nephropathy and class II lupus nephritis in patients with SLE


Disclosures: E. Kang: None; S. Hong: None.

To cite this abstract in AMA style:

Kang E, Hong S. A Comparative Study of Lupus Nephritis Class II and IgA Nephropathy: Renal Disease Other Than Lupus Nephritis in Systemic Lupus Erythematosus Patients [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/a-comparative-study-of-lupus-nephritis-class-ii-and-iga-nephropathy-renal-disease-other-than-lupus-nephritis-in-systemic-lupus-erythematosus-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-comparative-study-of-lupus-nephritis-class-ii-and-iga-nephropathy-renal-disease-other-than-lupus-nephritis-in-systemic-lupus-erythematosus-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology